Theratechnologies to Present at the Piper Sandler Virtual Healthcare Conference
MONTREAL, Nov. 23, 2020 – Theratechnologies (TSX: TH, NASDAQ: THTX) announced participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1-2, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MONTREAL, Nov. 23, 2020 – Theratechnologies (TSX: TH, NASDAQ: THTX) announced participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1-2, 2020. Paul Levesque, President and CEO, will be featured in a pre-recorded fireside chat available for online viewing. Interested parties can access the chat via the company's website. Theratechnologies is dedicated to developing innovative therapies for unmet medical needs. For more details, visit www.theratech.com.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +2.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that some of its management team members will be participating in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1 and 2, 2020.
In advance of the virtual conference and investor meetings, a pre-recorded fireside chat with Paul Levesque, President and Chief Executive Officer of Theratechnologies, is now available for viewing. To access the fireside chat, please click here. The link is also posted to the ‘News’ section of the Company’s website.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.